Connection

Kathrin Jansen to Vaccination

Back to Details
This is a "connection" page, showing publications Kathrin Jansen has written about Vaccination.
Kathrin Jansen
Connection Strength
0.098
Vaccination
  1. Persistence and 4-year boosting of the bactericidal response elicited by two- and three-dose schedules of MenB-FHbp: A phase 3 extension study in adolescents. Vaccine. 2019 03 14; 37(12):1710-1719.
    View in: PubMed
    Score: 0.031
  2. SA4Ag, a 4-antigen Staphylococcus aureus vaccine, rapidly induces high levels of bacteria-killing antibodies. Vaccine. 2017 02 22; 35(8):1132-1139.
    View in: PubMed
    Score: 0.027
  3. BNT162b vaccines protect rhesus macaques from SARS-CoV-2. Nature. 2021 04; 592(7853):283-289.
    View in: PubMed
    Score: 0.009
  4. Phase 1 trial of a 20-valent pneumococcal conjugate vaccine in healthy adults. Vaccine. 2019 09 30; 37(42):6201-6207.
    View in: PubMed
    Score: 0.008
  5. Two Vaccines for Staphylococcus aureus Induce a B-Cell-Mediated Immune Response. mSphere. 2018 08 22; 3(4).
    View in: PubMed
    Score: 0.008
  6. From research to licensure and beyond: clinical development of MenB-FHbp, a broadly protective meningococcal B vaccine. Expert Rev Vaccines. 2018 06; 17(6):461-477.
    View in: PubMed
    Score: 0.008
  7. Immunogenicity and safety of 13-valent pneumococcal conjugate vaccine (PCV13) formulated with 2-phenoxyethanol in multidose vials given with routine vaccination in healthy infants: An open-label randomized controlled trial. Vaccine. 2017 05 31; 35(24):3256-3263.
    View in: PubMed
    Score: 0.007
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.